Fierce Biotech
Endogenex nets $50M to carry intestinal diabetes procedure to the FDA
The fundraising comes after clinical results showed its system met safety goals and led to metabolic improvements in HbA1c, fasting glucose levels and body weight.
The fundraising comes after clinical results showed its system met safety goals and led to metabolic improvements in HbA1c, fasting glucose levels and body weight.